MedPath

石家庄四药有限公司

Ownership
-
Established
1994-06-28
Employees
-
Market Cap
-
Website
https://www.sjzsiyao.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

377

NMPA:377

Drug Approvals

Levocarnitine Oral Solution

Product Name
左卡尼汀口服溶液
Approval Number
国药准字H20254530
Approval Date
Jun 10, 2025
NMPA

Timolol Maleate Eye Drops

Product Name
马来酸噻吗洛尔滴眼液
Approval Number
国药准字H20254432
Approval Date
Jun 3, 2025
NMPA

Timolol Maleate Eye Drops

Product Name
马来酸噻吗洛尔滴眼液
Approval Number
国药准字H20254418
Approval Date
Jun 3, 2025
NMPA

Calcium Gluconate and Sodium Chloride Injection

Product Name
葡萄糖酸钙氯化钠注射液
Approval Number
国药准字H20254348
Approval Date
May 27, 2025
NMPA

Potassium Chloride Granules

Product Name
氯化钾颗粒
Approval Number
国药准字H20254319
Approval Date
May 27, 2025
NMPA

Dronedarone Hydrochloride Tablets

Product Name
盐酸决奈达隆片
Approval Number
国药准字H20254075
Approval Date
May 13, 2025
NMPA

Gabexate Mesylate for Injection

Product Name
注射用甲磺酸加贝酯
Approval Number
国药准字H20254110
Approval Date
May 13, 2025
NMPA

Ibuprofen Arginine Granules

Product Name
精氨酸布洛芬颗粒
Approval Number
国药准字H20253922
Approval Date
Apr 15, 2025
NMPA

Dapagliflozin and Metformin Hydrochloride Sustained-release Tablets (Ⅰ)

Product Name
达格列净二甲双胍缓释片(Ⅰ)
Approval Number
国药准字H20253948
Approval Date
Apr 15, 2025
NMPA

Ibuprofen Arginine Granules

Product Name
精氨酸布洛芬颗粒
Approval Number
国药准字H20253904
Approval Date
Apr 15, 2025
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 38
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.